Dilated cardiomyopathy: improving care and seeking a cure
There is no cure for dilated cardiomyopathy and no treatments specifically for the condition. We’ve been funding research to change this.
There is no cure for dilated cardiomyopathy and no treatments specifically for the condition. We’ve been funding research to change this.
Thousands of people in the UK have heart valve replacement each year, and many benefit from the advances that we’ve made possible.
Some people with Marfan syndrome have weak blood vessels at risk of bursting. This can be fatal. We’ve been funding research to stop this.
BHF-funded research helped identify the faulty genes causing hypertrophic cardiomyopathy and helped make genetic testing available to those affected.
Around 13 babies in the UK are diagnosed with congenital heart disease daily. We’re funding research to understand why.
We’ve supported crucial breakthroughs that have improved the care for patients with congenital heart disease, from birth to adulthood.
Our research has helped develop a tool to spot the risk of sudden cardiac death in children with hypertrophic cardiomyopathy, so it can be prevented.
We've funded research showing the value of MRI scans, as well as improving the scans and making them more available.